학술논문
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Document Type
Article
Author
Subbiah, Vivek ; Lassen, Ulrik; Élez, Elena; Italiano, Antoine; Curigliano, Giuseppe; Javle, Milind; de Braud, Filippo; Prager, Gerald W; Greil, Richard; Stein, Alexander; Fasolo, Angelica; Schellens, Jan H M; Wen, Patrick Y; Viele, Kert; Boran, Aislyn D; Gasal, Eduard; Burgess, Paul; Ilankumaran, Palanichamy; Wainberg, Zev A
Source
In The Lancet Oncology September 2020 21(9):1234-1243
Subject
Language
ISSN
1470-2045